Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

1.0K
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.0K
Renal Corpuscle01:20

Renal Corpuscle

9.5K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
9.5K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

2.0K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.0K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

1.0K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.0K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

357
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
357
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

488
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
488

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping the plasma proteomic architecture of systemic lupus erythematosus.

JCI insight·2026
Same author

Persistent Hematuria and Proteinuria in a Patient with SLE Nephritis.

Kidney360·2026
Same author

Sabbatical.

Academic medicine : journal of the Association of American Medical Colleges·2026
Same author

Complement biomarkers during iptacopan treatment.

Lancet (London, England)·2026
Same author

C4b-binding protein as an antigenic target in the pathogenesis of antiphosphatidylethanolamine autoantibodies.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

A novel fusion protein reduces kidney complement in experimental C3 glomerulopathy.

Clinical and experimental immunology·2026
Same journal

Crystal-Storing Histiocytosis Causing Severe AKI.

Kidney international·2026
Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026
Same journal

COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody-positive immune-complex nephritis.

Kidney international·2026
Same journal

Monitoring anti-nephrin antibodies in the management of recurrent diffuse podocytopathy.

Kidney international·2026
Same journal

The "Hear My Last Wish" Initiative: Leveraging Voiceprint Technology to Bridge the Gap Between Donor Intent and Family Consent in Taiwan.

Kidney international·2026
Same journal

A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease.

Kidney international·2026
See all related articles

Related Experiment Video

Updated: Apr 13, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

3.0K

IgM exacerbates glomerular disease progression in complement-induced glomerulopathy.

Sarah E Panzer1, Jennifer Laskowski2, Brandon Renner2

  • 1Division of Nephrology, Department of Medicine, University of Wisconsin Madison, Madison, Wisconsin, USA.

Kidney International
|May 7, 2015
PubMed
Summary
This summary is machine-generated.

Natural IgM antibodies specifically bind to damaged glomeruli, contributing to kidney disease progression. Studies show IgM exacerbates glomerular damage in a mouse model, highlighting its role beyond passive trapping.

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.1K
Assessment of Kidney Function in Mouse Models of Glomerular Disease
09:16

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Published on: June 30, 2018

18.9K

Related Experiment Videos

Last Updated: Apr 13, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

3.0K
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.1K
Assessment of Kidney Function in Mouse Models of Glomerular Disease
09:16

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Published on: June 30, 2018

18.9K

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Glomerular immunoglobulin M (IgM) deposition is observed in various kidney diseases, but its mechanism and significance are debated.
  • Previous theories suggested passive trapping of IgM in glomerulosclerosis, but recent findings indicate specific binding to damaged glomeruli.

Purpose of the Study:

  • To investigate if natural IgM binds to neo-epitopes on glomeruli after injury.
  • To determine IgM's role in exacerbating glomerular disease in a mouse model lacking factor H (a complement regulator).

Main Methods:

  • Utilized a mouse model deficient in factor H (FH) and B cells.
  • Employed immunofluorescence microscopy and ultrastructural analysis to detect IgM deposition.
  • Performed in vitro binding assays with cultured mesangial cells and in vivo experiments injecting purified IgM.

Main Results:

  • IgM deposition was observed in the mesangium and capillary loops, specifically on endothelial cells and subendothelial areas.
  • B cell-deficient, FH-deficient mice showed significantly reduced renal damage.
  • Injected IgM bound to glomeruli and induced proteinuria in B cell-deficient mice, with a monoclonal IgM recognizing phospholipids also causing albuminuria.

Conclusions:

  • Natural IgM antibodies specifically recognize and bind to glomerular neo-epitopes exposed after injury.
  • IgM actively contributes to the progression of glomerular damage in non-sclerotic glomerular disease models.
  • Findings challenge passive trapping theories and establish a direct role for IgM in exacerbating kidney disease.